EUVIMEDEUVIMED entdecken
Open Access

Nucleosome repositioning in chronic lymphocytic leukemia

Kristan V Piroeva, Charlotte McDonald, Charalampos Xanthopoulos, Chelsea Fox, Christopher T Clarkson, Jan-Philipp Mallm, Yevhen Vainshtein, Luminita Ruje, Lara C Klett, Stephan Stilgenbauer, Daniel Mertens, Efterpi Kostareli iD und 2 weitere

Genome Research · 2023-10 · 33 (10) · 1649-1661

DOI: 10.1101/gr.277298.122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genome Research, online erschienen am 12.09.2023. Verfasst von Kristan V Piroeva und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, University of Essex, Wivenhoe Park, Colchester CO4 3SQ, United Kingdom. Hauptthemen laut MEDLINE: Nucleosomes, Leukemia, Lymphocytic, Chronic, B-Cell. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, Cancer Research UK, Academy of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The location of nucleosomes in the human genome determines the primary chromatin structure and regulates access to regulatory regions. However, genome-wide information on deregulated nucleosome occupancy and its implications in primary cancer cells is scarce. Here, we conducted a genome-wide comparison of high-resolution nucleosome maps in peripheral blood B cells from patients with chronic lymphocytic leukemia (CLL) and healthy individuals at single-base-pair resolution. Our investigation uncovered significant changes of nucleosome positioning in CLL. Globally, the spacing between nucleosomes—the nucleosome repeat length (NRL)—is shortened in CLL. This effect is stronger in the more aggressive IGHV-unmutated CLL subtype than in the IGHV-mutated CLL subtype. Changes in nucleosome occupancy at specific sites are linked to active chromatin remodeling and reduced DNA methylation. Nucleosomes lost or gained in CLL marks differential binding of 3D chromatin organizers such as CTCF as well as immune response–related transcription factors and delineated mechanisms of epigenetic deregulation. The principal component analysis of nucleosome occupancy in cancer-specific regions allowed the classification of samples between cancer subtypes and normal controls. Furthermore, patients could be better assigned to CLL subtypes according to differential nucleosome occupancy than based on DNA methylation or gene expression. Thus, nucleosome positioning constitutes a novel readout to dissect molecular mechanisms of disease progression and to stratify patients. Furthermore, we anticipate that the global nucleosome repositioning detected in our study, such as changes in the NRL, can be exploited for liquid biopsy applications based on cell-free DNA to stratify patients and monitor disease progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NucleosomesLeukemia, Lymphocytic, Chronic, B-CellHumansChromatinTranscription FactorsDisease Progression

Substanzen

NucleosomesChromatinTranscription Factors

Autor:innen und Institutionen

  • School of Life Sciences, University of Essex, Wivenhoe Park, Colchester CO4 3SQ, United Kingdom.
  • Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast BT9 7BL, United Kingdom.
  • German Cancer Research Center (DKFZ) Heidelberg, Single Cell Open Lab, 69120 Heidelberg, Germany.
  • German Cancer Research Center (DKFZ) Heidelberg, Division of Chromatin Networks, 69120 Heidelberg, Germany.
  • Center for Quantitative Analysis of Molecular and Cellular Biosystems (BioQuant), Heidelberg University, 69120 Heidelberg, Germany.
  • Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB, 70569 Stuttgart, Germany.

ORCID-Profile: Efterpi Kostareli, Karsten Rippe, Vladimir B Teif

Förderung

  • Wellcome Trust
  • Cancer Research UK
  • Academy of Medical Sciences

Zitieren

APA

Piroeva, K. V., McDonald, C., Xanthopoulos, C., Fox, C., Clarkson, C. T., Mallm, J. P., Vainshtein, Y., Ruje, L., Klett, L. C., Stilgenbauer, S., Mertens, D., Kostareli, E., Rippe, K., & Teif, V. B. (2023). Nucleosome repositioning in chronic lymphocytic leukemia. Genome Research, 33(10), 1649-1661. https://doi.org/10.1101/gr.277298.122

Vancouver

Piroeva KV, McDonald C, Xanthopoulos C, Fox C, Clarkson CT, Mallm JP, et al. Nucleosome repositioning in chronic lymphocytic leukemia. Genome Research. 2023;33(10):1649-1661. doi:10.1101/gr.277298.122

BibTeX
@article{Piroeva2023,
  author = {Piroeva, Kristan V and McDonald, Charlotte and Xanthopoulos, Charalampos and Fox, Chelsea and Clarkson, Christopher T and Mallm, Jan-Philipp and Vainshtein, Yevhen and Ruje, Luminita and Klett, Lara C and Stilgenbauer, Stephan and Mertens, Daniel and Kostareli, Efterpi and Rippe, Karsten and Teif, Vladimir B},
  title = {Nucleosome repositioning in chronic lymphocytic leukemia},
  journal = {Genome Research},
  year = {2023},
  volume = {33},
  number = {10},
  pages = {1649--1661},
  doi = {10.1101/gr.277298.122}
}
Kostenlos starten →